We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Qimonda AG Ads | NYSE:QI | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
Quintiles, a Fortune 500 company, is the world’s largest provider of biopharmaceutical development and commercial outsourcing services. With a network of more than 30,000 employees conducting business in approximately 100 countries, we helped develop or commercialize all of 2013’s top-100 best-selling drugs on the market.
Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes.
At Quintiles, we improve customers’ probability of success by connecting insights with superior delivery.
This is our way of working together differently to shape ideas, execute effectively and share success. Today, Quintiles brings a fully integrated approach to build biopharma and life sciences solutions -- from pipeline through portfolio to population health. The goals customers set define the work we do and the standards we work to achieve.
PRODUCT DEVELOPMENT
Our Product Development group enables biopharmaceutical companies, including medical device companies and diagnostics companies, to outsource clinical development, from first-in-human studies to post-launch monitoring.
Our comprehensive services provide scientific and analytical expertise, global access, best in class technology, and local and global regulatory expertise at each stage of development to help our customers improve product development efficiency and effectiveness. Product Development is comprised Clinical solutions and services include project management and clinical monitoring functions for conducting multi-site trials (generally Phase II-IV), collectively known as “core clinical.”
Our global laboratories, data management, biostatistics, safety and pharmacovigilance, early clinical development (generally Phase I), and strategic planning and design services enable us to provide end-to-end solutions to our customers. Consulting provides strategy and management consulting services based on life science expertise and advanced analytics, as well as regulatory and compliance consulting services.
INTEGRATED HEALTHCARE SERVICES (IHS)
Quintiles’ Integrated Healthcare Services (IHS) address the outsourced commercial needs of biopharmaceutical customers as well as the needs of the broader healthcare sector for value-based analyses, research studies and evidence-based medicine.
Service offerings include commercial services such as sales representatives, strategy, market access, marketing communications and other areas related to commercialization.
Outcomes research including drug therapy analysis, real-world research and evidence-based medicine, including research studies to prove a drug’s value are also part of our IHS offering along with comparative and cost-effectiveness research, clinical management analytics, decision support services, medication adherence and health outcome optimization services, and web-based systems for measuring quality improvement.
Company:
QuintilesHeadquarters Address:
4820 Emperor Boulevard Durham, NC 27703Main Telephone:
919.998.2000Website:
www.Quintiles.com
Ticker/ISIN:
Q(NYSE)/US74876Y1010
Type of Organization:
PublicIndustry:
PharmaceuticalKey Executives:
CEO: Tom Pike
CFO: Kevin Gordon
Public Relations
Contact:
Phil BridgesPhone:
919.998.1653
Email:
phil.bridges@quintiles.com
Public Relations
Contact:
Mari MansfieldPhone:
919.998.2639Email:
mari.mansfield@quintiles.com
Investor Relations
Contact:
Karl Deonanan
Phone:
919.998.2789
Email:
InvestorRelations@quintiles.com
1 Year Qimonda AG Ads Chart |
1 Month Qimonda AG Ads Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions